Investigation of apoptosis mechanism of Pae on human esophageal cancer Eca-109 cell carcinoma xenograft in nude mice

Chinese Pharmacological Bulletin

Volumn 24, Issue 4, 2008, Pages

  Liu, Si Han ^a   Sun, Guo Ping ^a   Yang, Zhen ^a   Wan, Xin An ^a   Wang, Zhang Gui ^a   Wu, Hong Yang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2; COX 2; Eca 109 cell; Esophageal carcinoma; Paeonol; Survivin

Indexed keywords

CISPLATIN; CYCLOOXYGENASE 2 INHIBITOR; PEONOL; PROTEIN BCL 2; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ESOPHAGUS CANCER; IMMUNOHISTOCHEMISTRY; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

EID: 45349087061     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kaufmann S H, Vaux D L. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance[J]. Oncogene,2003, 22(47):7414-30.
2. Yang Z, Sun G P, Xu S P, et al. Studies on anti-proliferation and inducing apoptosis effects of paeonol on human esophageal cancer cell line Eca-109 in vitro and in vivo[J]. Chin Pharmacol Bull,2007,23(5):654-8.
3. Wang X A, Sun G P, Xu S P, et al. Synergistic anti-tumor effect of paeonol and cisplatin on human esophageal cancer cell line Eca-109[J]. Acta Univ Med Anhui,2007,42(3):306-8.
4. Zimmermann K C, Sarbia M, Weber A A, et al. Cyclooxygenase-2 expression in human esophageal carcinoma[J]. Cancer Res,1999, 59(1):198-204.
5. Farrow D C, Vaughan T L, Hansten P D, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer[J]. Cancer Epidemiol Biomarkers Prev,1998,7 (2):97-102.
6. Zhang Y J, Liu S X, Qi F Y, et al. Induction and mechanism of valdecoxib on the apoptosis of human esophageal cancer cells[J]. Chin Pharmacol Bull,2006,22(5):629-33.
7. Zhang L X, Jin C T, Li Y Z, et al. COX-2 inhibitor (Aspirin) inhibited proliferation and induced apoptosis of human esophageal carcinoma in vitro[J]. Tumor,2007,27(3):181-5.
8. Jin C T, Lu B, Li H J, et al. Effects of cyclooxygenase-2 selective inhibitor NS-398 on the proliferation and apoptosis of human esophageal carcinoma cell lines[J]. World J Gastroenterol,2007,15 (5):440-6.
9. Li Y M, Yang X R. Study of expression of urvivin and COX-2 in esophageal squamous carcinoma and their relationship[J]. Chin J Clin Gastroenterol,2006,18(6):353-5.
10. Tsujimoto Y, Cossman J, Jaffe E, et al. Involvement of the bcl-2 gene in human follicular lymphoma[J]. Science. 1985,228 (4706):1440-3.
11. Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma[J]. Nat Med,1997,3 (8):917-21.
12. 2 in human colon cancer cells [J]. Cancer Res,1998,58(2):362-6.
13. Nishihara H, Kizaka-Kondoh S, Insel P A, et al. Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2[J]. Proc Natl Acad Sci USA,2003,100(15):8921-6.
14. Yamanaka Y, Shiraki K, Inoue T, et al. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis [J]. Int J Mol Med,2006,18(1):41-7.